HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effect of the cytokine rhTNF-alpha on the population of mast cells in the growth of MethA fibrosarcoma--a TEM study.

Abstract
The aim of the present study was the ultrastructural characteristics of mast cell (MC) involved in host antitumor responses induced by local (i.t.) administration of recombinant human tumor necrosis factor alpha (rhTNF-alpha) in the primary focus of methA fibrosarcoma. MC were involved in tumor interstitium remodeling. Numerous mitochondria, well-developed RER and Golgi apparatus, clusters of polyribosomes, considerable polymorphism of granules and differentiated lamellar structures which frequently presented myelinic forms were observed after rhTNF-alpha application. In the study numerous fibres of the fibrous tissue, richly vascularized, occurred in the peripheral and intermediate tumor zones. Cluster of MC and tumor cells were seen on the border of the necrotic foci. However, proteolytic enzymes released by MC cause interstitial lysis, ensuring the place for tumor growth, and are involved in angiogenesis. Thus, it is not clear whether MC contribute to the inhibition of tumor growth or have an adjunctive role in tumor progression.
AuthorsS J Terlikowski, H F Nowak, W Famulski, M Sulkowska
JournalFolia histochemica et cytobiologica (Folia Histochem Cytobiol) Vol. 39 Suppl 2 Pg. 199-200 ( 2001) ISSN: 0239-8508 [Print] Poland
PMID11820606 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antineoplastic Agents
  • Recombinant Proteins
  • Tumor Necrosis Factor-alpha
  • Methylcholanthrene
Topics
  • Animals
  • Antineoplastic Agents (pharmacology)
  • Female
  • Fibrosarcoma (chemically induced, drug therapy, pathology)
  • Male
  • Mast Cells (pathology, ultrastructure)
  • Methylcholanthrene
  • Mice
  • Mice, Inbred Strains
  • Microscopy, Electron
  • Neoplasms, Connective Tissue (chemically induced, drug therapy, pathology)
  • Recombinant Proteins (pharmacology)
  • Tumor Necrosis Factor-alpha (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: